X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/aacr-2024-annual-meeting-visit-senhwa-biosciences-exhibit-booth-302106955.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-first-patient-dosed-in-the-phase-ii--study-of-silmitasertib-in-patients-with-community-acquired-pneumonia-associated-with-viral-infection-in-taiwan-302094217.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-received-us-fda-ind-approval-for-phase-ii-study-of-silmitasertib-in-patients-with-community-acquired-pneumonia-cap-associated-with-viral-infection-301994554.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-first-patient-successfully-dosed-in-taiwan-phase-ii-study-of-silmitasertib-in-hospitalized-adults-with-covid-19-301982962.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-ind-submission-to-us-fda-for-phase-ii-study-of-silmitasertib-in-patients-with-community-acquired-pneumonia-cap-associated-with-viral-infection-301961780.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-received-taiwan-fda-ind-approval-for-phase-ii-study-of-silmitasertib-in-patients-with-moderate-to-severe-covid-19-301810732.html
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-successful-awardee-of-anticancer-pipeline-pidnarulex-in-nih-sponsored-next-program-301691159.html
https://www.prnewswire.com/news-releases/senhwa-announces-first-patient-successfully-dosed-in-phase-i-study-of-pindnarulex-in-combination-with-pfizers-talazoparib-for-the-treatment-of-prostate-cancer-301663181.html
https://www.prnewswire.com/news-releases/senhwas-pindnarulex-in-combination-study-with-pfizers-talazoparib-for-the-treatment-of-prostate-cancer-granted-approval-to-initiate-from-australian-hrec-301561734.html
Market Place
Share 
